Main content area

The natural antisense transcript NATTD regulates the transcription of decapping scavenger (DcpS) enzyme

Mei, Zhu-Zhong, Sun, Hongwei, Ou, Xiaoli, Li, Lei, Cai, Junwei, Hu, Shuiwang, Wang, Juan, Luo, Haihua, Liu, Jinghua, Jiang, Yong
The international journal of biochemistry & cell biology 2019 v.110 pp. 103-110
DNA-directed RNA polymerase, chromatin, epigenetics, genes, messenger RNA, mice, muscular atrophy, non-coding RNA, precipitin tests, therapeutics, transcription (genetics)
Natural antisense transcripts (NATs) are transcribed from the opposite strand of other genes. Most of them are noncoding RNAs. They have been reported to play important roles in a variety of biological processes. In this study, we identified a novel NAT, NATTD, which is partially complementary to both the TIRAP/Mal and DcpS genes. Interestingly, NATTD only positively regulates the expression of DcpS, a decapping scavenger enzyme which is a promising therapeutic target for spinal muscular atrophy. But it has no obvious effects on the expression of TIRAP/Mal gene. The NATTD transcript primarily resides in the nucleus and does not alter the mRNA stability of DcpS. Instead, it is required for the recruitment of RNA polymerase II at the mouse DcpS promoter. Chromatin immunoprecipitation assays revealed that knocking-down NATTD transcript with shRNA enhanced the H3K27-Me3 modification at the DcpS promoter. In summary, our studies identified NATTD as a regulator of DcpS transcription through epigenetic mechanisms.